Early detection of hearing loss for infants in Western Australia: Comparison to international benchmarks.


Journal

Journal of paediatrics and child health
ISSN: 1440-1754
Titre abrégé: J Paediatr Child Health
Pays: Australia
ID NLM: 9005421

Informations de publication

Date de publication:
Mar 2022
Historique:
revised: 23 08 2021
received: 24 06 2021
accepted: 25 08 2021
pubmed: 14 9 2021
medline: 1 4 2022
entrez: 13 9 2021
Statut: ppublish

Résumé

To assess the degree to which timely audiological assessment of congenital hearing loss is achieved at our institution - Perth Children's Hospital, Western Australia, and to review cases which breached this timeframe in order to address barriers to timely assessment. The benchmark used to determine timely assessment is that set out by The Joint Committee on Infant Hearing (JCIH) in which diagnostic audiological testing occurs by three months of age for those who do not pass newborn hearing screening. A retrospective chart review of infants who underwent diagnostic auditory assessment at Perth Children's Hospital between 2016-2019. A total of 151 children were identified as meeting the inclusion criteria and their medical files were reviewed. Time to first dABR was the time point for whether testing was achieved within the 3 month timeframe. Of the 151 children who underwent dABR assessments, 1 was identified as having breached the 90 day time limit (tested on day 91) for which no valid reason for delay could be identified. The timely delivery of dABR assessments in 99.3% of cases within this cohort compares favourably with the literature. Conclusion Timely diagnostic audiological assessment is achievable for children with congenital hearing loss. The reasons for patients breaching this timeframe are explored in the paper along with factors which may help avoid delays.

Identifiants

pubmed: 34516698
doi: 10.1111/jpc.15733
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

422-426

Informations de copyright

© 2021 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).

Références

Morton CC, Nance WE. Newborn hearing screening - A silent revolution. N. Engl. J. Med. 2006; 354: 2151-64.
Kennedy C, McCann D. Universal neonatal hearing screening moving from evidence to practice. Arch. Dis. Child. 2004; 89: F378-83.
Lieu JEC. Speech-language and educational consequences of unilateral hearing loss in children. Arch. Otolaryngol. Head Neck Surg. 2004; 130: 524-30.
Bess FH, Tharpe AM. Unilateral hearing impairment in children. Pediatrics 1984; 74: 206-16.
Brookhouser PE, Worthington DW, Kelly WJ. Unilateral hearing loss in children. Laryngoscope 1991; 101: 1264-72.
Smith B, Zhang J, Pham GN et al. Effects of socioeconomic status on children with hearing loss. Int. J. Pediatr. Otorhinolaryngol. 2019; 116: 114-7.
Ching TYC. Is early intervention effective in improving spoken language outcomes of children with congenital hearing loss? Am. J. Audiol. 2015; 24: 345-8.
Sininger YS, Grimes A, Christensen E. Auditory development in early amplified children: Factors influencing auditory-based communication outcomes in children with hearing loss. Ear Hear. 2010; 31: 166-85.
Fulcher A, Purcell AA, Baker E, Munro N. Listen up: Children with early identified hearing loss achieve age-appropriate speech/language outcomes by 3 years-of-age. Int. J. Pediatr. Otorhinolaryngol. 2012; 76: 1785-94.
Yoshinaga-Itano C. Levels of evidence: Universal newborn hearing screening (UNHS) and early hearing detection and intervention systems (EHDI). J. Commun. Disord. 2004; 37: 451-65.
Kennedy CR, McCann DC, Campbell MJ et al. Language ability after early detection of permanent childhood hearing impairment. N. Engl. J. Med. 2006; 354: 2131-41.
Busa J, Harrison J, Chappell J et al. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics 2007; 120: 898-921.
Thompson DC, McPhillips H, Davis RL, Lieu TA, Homer CJHM. Universal newborn hearing screening: Summary of evidence. JAMA 2001; 286: 2000-10.
Wroblewska-Seniuk KE, Dabrowski P, Szyfter W, Mazela J. Universal newborn hearing screening: Methods and results, obstacles, and benefits. Pediatr. Res. 2017; 81: 415-22.
Wolff R, Hommerich J, Riemsma R, Antes G, Lange S, Kleijnen J. Hearing screening in newborns: Systematic review of accuracy, effectiveness, and effects of interventions after screening. Arch. Dis. Child. 2010; 95: 130-5.
Bailey HD, Bower C, Krishnaswamy J, Coates HL. Newborn hearing screening in Western Australia. Med. J. Aust. 2002; 177: 180-5.
Commissioner for Children and Young People. Profile of Children and Young People in WA - January 2020, Perth; 2020.
Bagatto M, Scollie SD, Hyde M, Seewald R. Protocol for the provision of amplification within the Ontario infant hearing program. Int. J. Audiol. 2010;49(Suppl. 1):S70-9.
Sutton G, Lightfoot G. Newborn Hearing Screening and Assessment - Guidance for Auditory Brainstem Response Testing in Babies; 2013. Available from: https://www.thebsa.org.uk/wp-content/uploads/2014/08/NHSP_ABRneonate_2014.pdf
Queensland Health. Audiology Diagnostic Assessment Protocol; 2016. Available from: https://www.childrens.health.qld.gov.au/wp-content/uploads/PDF/healthy-hearing/hh-audiology-protocol.pdf
McCreery RW, Kaminski J, Beauchaine K, Lenzen N, Simms K, Gorga MP. The impact of degree of hearing loss on auditory brainstem response predictions of behavioral thresholds. Ear Hear. 2015; 36: 309-19.
Polonenko MJ, Maddox RK. The parallel auditory brainstem response. Trends Hear. 2019; 23: 2331216519871395.
Zaitoun M, Cumming S, Purcell A, O'Brien K. The impact of clinical history on the threshold estimation of auditory brainstem response results for infants. J. Speech Lang. Hear. Res. 2017; 60: 725-31.
Beutelmann R, Laumen G, Tollin D, Klump GM. Amplitude and phase equalization of stimuli for click evoked auditory brainstem responses. J. Acoust. Soc. Am. 2015; 137: EL71-7.
Government of Western Australia. Department of Health; 2009. Available from: https://ww2.health.wa.gov.au/-/media/Files/Corporate/Policy-Frameworks/Clinical-Services-Planning-and-Programs/Policy/Newborn-Hearing-Screening/OD239-Newborn-Hearing-Screening.pdf
Kimberlin DW, Jester PM, Sánchez PJ et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N. Engl. J. Med. 2015; 372: 933-43.
Queensland Health. Screening Protocols and Guidelines. 2016; May 2017.
Graham J, Vickers D, Eyles J et al. Bilateral sequential cochlear implantation in the congenitally deaf child: Evidence to support the concept of a ‘critical age’ after which the second ear is less likely to provide an adequate level of speech perception on its own. Cochlear Implants Int. 2009; 10: 119-41.
Peters BR, Litovsky R, Parkinson A, Lake J. Importance of age and postimplantation experience on speech perception measures in children with sequential bilateral cochlear implants. Otol. Neurotol. 2007; 28: 649-57.
Government of Western Australia. Department of Health. Operational Directive-Newborn Hearing Screening. 2009: pp. 1-5.
Holte L, Walker E, Oleson J et al. Factors influencing follow-up to newborn hearing screening for infants who are hard of hearing. Am. J. Audiol. 2012; 21: 163-74.
Awad R, Oropeza J, Uhler KM. Meeting the Joint Committee on Infant Hearing standards in a large metropolitan children's hospital: Barriers and next steps. Am. J. Audiol. 2019; 28: 251-9.

Auteurs

Allison Reid (A)

Ear, Nose and Throat Department, Perth Children's Hospital, Perth, Western Australia, Australia.
School of Paediatrics, The University of Western Australia, Perth, Western Australia, Australia.

Sarah Firns (S)

Department of Audiology, The University of Western Australia, Perth, Western Australia, Australia.

Karina Tao (K)

Department of Hearing Research, Telethon Kids Institute, Perth, Western Australia, Australia.
Department of Audiology, Perth Children's Hospital, Perth, Western Australia, Australia.

Erin Maywood (E)

Department of Audiology, Perth Children's Hospital, Perth, Western Australia, Australia.

Hayley Herbert (H)

Ear, Nose and Throat Department, Perth Children's Hospital, Perth, Western Australia, Australia.

Wilhemina A M Mulders (WAM)

Clinical Audiology and Audiological Sciences, School of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia.

Jafri Kuthubutheen (J)

Ear, Nose and Throat Department, Perth Children's Hospital, Perth, Western Australia, Australia.
School of Surgery, The University of Western Australia, Perth, Western Australia, Australia.

Christopher Brennan-Jones (C)

Department of Audiology, Perth Children's Hospital, Perth, Western Australia, Australia.
Department of Ear Health, Telethon Kids Institute, Perth, Western Australia, Australia.
Department of Paediatrics, The University of Western Australia, Medical School, Perth, Western Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH